Reflecting growing national acceptance of cannabis, a bipartisan coalition of House members voted early Friday to restrict the Drug Enforcement Administration from using funds to go after medical marijuana operations that are legal under state laws. An appropriations amendment offered by Rep. Dana Rohrabacher (R-Calif.) prohibiting the DEA from spending funds to arrest state-licensed medical marijuana patients and providers passed 219-189. The Senate will likely consider its own appropriations bill for the DEA, and the House amendment would have to survive a joint conference before it could go into effect. Rohrabacher said on the House floor that the amendment "should be a no-brainer" for conservatives who support states' rights and argued passionately against allowing the federal government to interfere with a doctor-patient relationship. "Some people are suffering, and if a doctor feels that he needs to prescribe something to alleviate that suffering, it is immoral for this government to get in the way," Rohrabacher said, his voice rising. "And that's what's happening." Read more here
0 Comments
New guidelines were released today by the Department of Justice and the Treasury Department that will allow banks to do business with marijuana related businesses. Part of the text of the guidelines are here: "The Financial Crimes Enforcement Network (“FinCEN”) is issuing guidance to clarify Bank Secrecy Act (“BSA”) expectations for financial institutions seeking to provide services to marijuana-related businesses. FinCEN is issuing this guidance in light of recent state initiatives to legalize certain marijuana-related activity and related guidance by the U.S. Department of Justice (“DOJ”) concerning marijuana-related enforcement priorities. This FinCEN guidance clarifies how financial institutions can provide services to marijuana-related businesses consistent with their BSA obligations, and aligns the information provided by financial institutions in BSA reports with federal and state law enforcement priorities. This FinCEN guidance should enhance the availability of financial services for, and the financial transparency of, marijuana-related businesses In assessing the risk of providing services to a marijuana-related business, a financial institution should conduct customer due diligence that includes: (i) verifying with the appropriate state authorities whether the business is duly licensed and registered; (ii) reviewing the license application (and related documentation) submitted by the business for obtaining a state license to operate its marijuana-related business; (iii) requesting from state licensing and enforcement authorities available information about the business and related parties; (iv) developing an understanding of the normal and expected activity for the business, including the types of products to be sold and the type of customers to be served (e.g., medical versus recreational customers); (v) ongoing monitoring of publicly available sources for adverse information about the business and related parties; (vi) ongoing monitoring for suspicious activity, including for any of the red flags described in this guidance; and (vii) refreshing information obtained as part of customer due diligence on a periodic basis and commensurate with the risk. With respect to information regarding state licensure obtained in connection with such customer due diligence, a financial institution may reasonably rely on the accuracy of information provided by state licensing authorities, where states make such information available." Read the full guidelines here! |
AuthorSusan Soares has written for Cannabis Now Magazine, Alternet, and Sensi Magazine. Archives
June 2018
|